IMR OpenIR
Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China
Alternative TitleGeriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China
Zhong YuPing1; Zhang YiZhuo2; Liao AiJun3; Lil SuXia4; Tian Chen5; Lu Jin6
2017
Source PublicationChinese Medical Journal
ISSN0366-6999
Volume130Issue:2Pages:130-134
AbstractBackground: Elderly multiple myeloma (MM) patients often tend to suffer a variety of diseases, so the treatment of choice is very difficult for the elderly myeloma patients. The overall survival (OS) time and side effects with elderly patients are unclear in China. The study tried to find out the role of geriatric assessment in the Chinese elderly MM. Methods: We retrospectively analyzed the data of 628 newly diagnosed patients from six hospitals from June 2011 to June 2013. A geriatric assessment had been performed to assess comorbidities, cognitive, and physical status for these patients. The primary endpoint was to evaluate different physical states of elderly patients with OS time and treatment-related side effects. Results: An additive scoring system (range: 0-5), based on age, Katz′s Activity of Daily Living (ADL) and Lawton′s Instrumental Activity of Daily Living (IADL) ≤5 and Charlson Comorbidity Index (CCI) was developed to identify three groups: fit (score = 0); intermediate-fitness (score = 1); and frail (score ≥2). The 3-year OS was 63% in fit patients, 63% in intermediate-fitness patients, and 49% in frail patients ≥3 hematologic adverse events (AEs) were documented in 45 (35.4%) fit, 34 (34%) intermediate-fitness, and 121 (30.2%) frail patients. The risk of a grade ≥3 hematologic AEs was not significantly increase in intermediate-fitness (hazard ratios HR: 0.99, 95% confidence interval CI: 0.54-1.47, P = 1.000) and in frail patients (HR: 1.16, 95% CI: 0.70-1.93, P = 0.558) compared with fit ones. Conclusions: MM occurs earlier in life and being advanced when the diagnosis is made in the mainland of China. The overall survival in frailty with International Staging System (ISS) II/III was the worst in all patients.
Other AbstractBackground: Elderly multiple myeloma (MM) patients often tend to suffer a variety of diseases, so the treatment of choice is very difficult for the elderly myeloma patients. The overall survival (OS) time and side effects with elderly patients are unclear in China. The study tried to find out the role of geriatric assessment in the Chinese elderly MM. Methods: We retrospectively analyzed the data of 628 newly diagnosed patients from six hospitals from June 2011 to June 2013. A geriatric assessment had been performed to assess comorbidities, cognitive, and physical status for these patients. The primary endpoint was to evaluate different physical states of elderly patients with OS time and treatment-related side effects. Results: An additive scoring system (range: 0–5), based on age, Katz's Activity of Daily Living (ADL) and Lawton's Instrumental Activity of Daily Living (IADL) ≤5 and Charlson Comorbidity Index (CCI) was developed to identify three groups: fit (score = 0); intermediate-fitness (score = 1); and frail (score ≥2). The 3-year OS was 63% in fit patients, 63% in intermediate-fitness patients, and 49% in frail patients ≥3 hematologic adverse events (AEs) were documented in 45 (35.4%) fit, 34 (34%) intermediate-fitness, and 121 (30.2%) frail patients. The risk of a grade ≥3 hematologic AEs was not significantly increase in intermediate-fitness (hazard ratios HR : 0.99, 95% confidence interval CI : 0.54–1.47, P = 1.000) and in frail patients ( HR : 1.16, 95% CI : 0.70–1.93, P = 0.558) compared with fit ones. Conclusions: MM occurs earlier in life and being advanced when the diagnosis is made in the mainland of China. The overall survival in frailty with International Staging System (ISS) II
KeywordGeriatric Assessment Medicine R Multicenter Study Multiple Myeloma
Indexed ByCSCD
Language英语
Funding Project[National Natural Science Foundation of China]
CSCD IDCSCD:5900084
Citation statistics
Document Type期刊论文
Identifierhttp://ir.imr.ac.cn/handle/321006/148197
Collection中国科学院金属研究所
Affiliation1.Beijing Univ, Clin Res Institute, Capital Med Univ, Dept Hematol,Beijing Chaoyang Hosp West, Beijing 100043, Peoples R China
2.中国科学院合肥物质科学研究院肿瘤医院
3.中国科学院金属研究所
4.Peoples Liberat Army 301 Hosp, Department Hematol, Beijing 100853, Peoples R China
5.Peoples Liberat Army 304 Hosp, Department Hematol, Beijing 100048, Peoples R China
6.北京大学
Recommended Citation
GB/T 7714
Zhong YuPing,Zhang YiZhuo,Liao AiJun,et al. Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China[J]. Chinese Medical Journal,2017,130(2):130-134.
APA Zhong YuPing,Zhang YiZhuo,Liao AiJun,Lil SuXia,Tian Chen,&Lu Jin.(2017).Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China.Chinese Medical Journal,130(2),130-134.
MLA Zhong YuPing,et al."Geriatric Assessment to Predict Survival and Risk of Serious Adverse Events in Elderly Newly Diagnosed Multiple Myeloma Patients: A Multicenter Study in China".Chinese Medical Journal 130.2(2017):130-134.
Files in This Item:
There are no files associated with this item.
Related Services
Recommend this item
Bookmark
Usage statistics
Export to Endnote
Google Scholar
Similar articles in Google Scholar
[Zhong YuPing]'s Articles
[Zhang YiZhuo]'s Articles
[Liao AiJun]'s Articles
Baidu academic
Similar articles in Baidu academic
[Zhong YuPing]'s Articles
[Zhang YiZhuo]'s Articles
[Liao AiJun]'s Articles
Bing Scholar
Similar articles in Bing Scholar
[Zhong YuPing]'s Articles
[Zhang YiZhuo]'s Articles
[Liao AiJun]'s Articles
Terms of Use
No data!
Social Bookmark/Share
All comments (0)
No comment.
 

Items in the repository are protected by copyright, with all rights reserved, unless otherwise indicated.